Report Categories
View AllRecent Articles
View All
Celularity CELU What Lies Ahead Celularity Inc posts 425 EPS beat narrower loss
RCKY Rocky Brands Inc posts 90 percent EPS beat for Q4 2025 lifting shares 383 percent in todays trading session
North NRT Stock Floor Levels Investor Concern 20260418
Berkshire Hathaway Rebuilds Airline Exposure with 26 Billion Delta Stake
HighYield Savings Rates Reach Up to 41 APY on May 24 2026
Memory Chip ETF Surges Past 10 Billion as AI Demand Drives Record Inflows
UKGulf Trade Deal Hailed as Monumental Achievement by Bahrain Minister
Secondary Market for Anthropic Shares Heats Up Raising Fraud Concerns
Hexcel Corporation HXL Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Aerospace Demand
MCRB Q1 2026 Earnings EPS Misses Estimates Revenue Not Reported Stock Declines
Rollins Inc ROL Q1 2026 Earnings EPS Edges Past Estimates Shares Dip Slightly
FSLR Q1 2026 Earnings EPS Beat Bolstered by Strong Operating Performance and Demand Tailwinds
CRVO Q1 2026 Earnings EPS Miss Reflects Continued Clinical Investment
Future FinTech Group Inc FTFT Hovers Near Support After Modest Decline
JM Smucker SJM Rallies 175 as Shares Test Key Resistance Zone
Pimco New York Municipal Income Fund II PNI Holds Near Support Amid Modest Selling Pressure
Miluna Acquisition Corp MMTX Holds Steady at 1007 as Trading Remains Subdued
Front Row at Indy 500 A Decisive Financial Advantage for Teams and Manufacturers
SK Hynix and Micron Join the 1 Trillion Market Cap Club as AI Rally Intensifies
IRS Settlement Blocks Tax Audits Targeting President Trump and Family Businesses
US Treasury Yields Edge Lower as Iran Peace Deal Optimism Tempers Geopolitical Uncertainty
Riskified Ltd RSKD Nears Key Support After Minor Decline
OneStream Inc OS Holds Steady at 240 as Key Levels Test Patience
IGIC Experiences a Mild Downside as Stock Consolidates Near Key Levels
Hall Chadwick Acquisition Corp Rights HCACR Holds Steady at 029 Sideways Action in a Tight Range
Stellantis STLA Rebounds Sharply Key Levels to Watch After Surge
AN2 Therapeutics ANTX Eases 21 Testing Key Support Near 440